Ozagrel sodium
Modify Date: 2025-08-28 23:20:57
Ozagrel sodium structure
|
Common Name | Ozagrel sodium | ||
|---|---|---|---|---|
| CAS Number | 189224-26-8 | Molecular Weight | 250.228 | |
| Density | N/A | Boiling Point | 468ºC at 760 mmHg | |
| Molecular Formula | C13H11N2NaO2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 236.8ºC | |
Use of Ozagrel sodiumOzagrel Sodium, also known as KCT-0809 and Cataclot, is a thromboxane A2 synthase inhibitor used to treat cerebrovascular diseases. |
| Name | sodium,(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate |
|---|---|
| Synonym | More Synonyms |
| Boiling Point | 468ºC at 760 mmHg |
|---|---|
| Molecular Formula | C13H11N2NaO2 |
| Molecular Weight | 250.228 |
| Flash Point | 236.8ºC |
| Exact Mass | 250.071823 |
| PSA | 57.95000 |
| LogP | 0.69450 |
| Storage condition | -20℃ |
| XanbonS |
| OKY-046 sodium |
| sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]prop-2-enoate |
| Kadenin |
| Sodium Ozagrel |
| 2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt, (2E)- (1:1) |
| Xanbon |
| Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate |
| Cataclot |
| Ozagrel Sodium |
| Athrombone |